Lawrence Bloch
Chief Executive Officer at NeurAxon Pharma, Inc.
Net worth: 97 $ as of 30/01/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David W. Beier | M | 75 | 6 years | |
| Richard Gaynor | M | 74 | 4 years | |
| Frank Porreca | M | - |
NeurAxon Pharma, Inc.
 NeurAxon Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services NeurAxon Pharma, Inc. researches and develops nervous system disorder therapies. The company is headquartered in Mississauga, Canada. | - |
| Jennifer Roberts | F | - | 7 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Gerald Quirk | M | 56 | 6 years | |
| Christopher M. Lindblom | M | 52 | 8 years | |
| Sujay Kango | M | 60 | 4 years | |
| Thomas Lynch | M | 63 | 5 years | |
| James G. Ham | M | 74 |
NitroMed, Inc.
 NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA. | 4 years |
| Patrick Lee | M | 67 | 7 years | |
| Jeffrey Berkowitz | M | 58 | 6 years | |
| Tamyra A. Toole | F | - |
NitroMed, Inc.
NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA. | 12 years |
| Martin Babler | M | 59 | 6 years | |
| Gwen A. Fyfe | M | 72 | 4 years | |
| José Baselga | M | 65 | 3 years | |
| Vito Palombella | M | 61 | 12 years | |
| Michael Kauffman | M | 60 | 3 years | |
| Samuel Agresta | M | 51 | 5 years | |
| Ian Smith | M | 58 | 11 years | |
| Michael C. Venuti | M | 70 | 17 years | |
| Eric S. Lander | M | 67 | 10 years | |
| Steven Holtzman | M | 70 | 17 years | |
| Jaren Madden | F | - | 7 years | |
| Keith Manchester | M | 55 |
Applied Molecular Evolution, Inc.
 Applied Molecular Evolution, Inc. Medical/Nursing ServicesHealth Services Applied Molecular Evolution, Inc. provides healthcare support services. It develops novel human biotherapeutics cytokines, hormones, and enzymes. The company was founded in 1989 by Bill Huse and is headquartered in San Diego, CA. | - |
| Scott Barrett | M | 61 | 2 years | |
| Robert Ilaria | M | 63 | 2 years | |
| John Lee | M | 56 | 15 years | |
| Stéphane Peluso | M | 54 | 2 years | |
| Jayne Kauffman | F | - | - | |
| David Roth | M | 61 | 2 years | |
| Joseph Pearlberg | M | 60 | 3 years | |
| Deborah Miller | M | 48 | 7 years | |
| Marie-Louise Fjaellskog | M | 59 | 1 years | |
| James Porter | M | 48 | 14 years | |
| Patrick F. Kelly | M | 60 | 3 years | |
| Michael Landsittel | M | 52 | - | |
| Michael Ferraresso | M | - | 4 years | |
| Jeffery L. Kutok | M | 57 | 10 years | |
| Suresh Mahabhashyam | M | - | - | |
| Ronald Vigliotta | M | 51 | 7 years | |
| William Bertrand | M | 59 | 1 years | |
| Winston K. C. Lam | M | - | - | |
| Deepa Pakianathan | M | 59 |
NeurAxon, Inc.
 NeurAxon, Inc. Miscellaneous Commercial ServicesCommercial Services NeurAxon, Inc. is engaged in the research and development of growing and unmet needs for chronic pain management. It is focused on developing pain therapeutics targeting neuronal Nitric Oxide Synthase (nNOS) inhibitors. The companyw as founded in 2004 and is headquartered in Mississauga, ON. | - |
| Lisa Kelly-Croswell | F | 57 |
NitroMed, Inc.
NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA. | 1 years |
| William Jones | M | 60 |
NitroMed, Inc.
NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA. | 3 years |
| Pedro D. Santabarbara | M | 71 | 4 years | |
| William Larry Respess | M | 85 |
Applied Molecular Evolution, Inc.
Applied Molecular Evolution, Inc. Medical/Nursing ServicesHealth Services Applied Molecular Evolution, Inc. provides healthcare support services. It develops novel human biotherapeutics cytokines, hormones, and enzymes. The company was founded in 1989 by Bill Huse and is headquartered in San Diego, CA. | 2 years |
| Frank Douglas | M | 80 |
NitroMed, Inc.
NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA. | 4 years |
| Sam Wertheimer | M | 63 |
NeurAxon, Inc.
NeurAxon, Inc. Miscellaneous Commercial ServicesCommercial Services NeurAxon, Inc. is engaged in the research and development of growing and unmet needs for chronic pain management. It is focused on developing pain therapeutics targeting neuronal Nitric Oxide Synthase (nNOS) inhibitors. The companyw as founded in 2004 and is headquartered in Mississauga, ON. | 3 years |
| Julian Adams | M | 69 | 11 years | |
| James Breitmeyer | M | 70 |
Applied Molecular Evolution, Inc.
Applied Molecular Evolution, Inc. Medical/Nursing ServicesHealth Services Applied Molecular Evolution, Inc. provides healthcare support services. It develops novel human biotherapeutics cytokines, hormones, and enzymes. The company was founded in 1989 by Bill Huse and is headquartered in San Diego, CA. | 5 years |
| Morten Vigeland | M | - |
Applied Molecular Evolution, Inc.
Applied Molecular Evolution, Inc. Medical/Nursing ServicesHealth Services Applied Molecular Evolution, Inc. provides healthcare support services. It develops novel human biotherapeutics cytokines, hormones, and enzymes. The company was founded in 1989 by Bill Huse and is headquartered in San Diego, CA. | 3 years |
| Brian Schwartz | M | 52 | 2 years | |
| Welton O'Neal | M | - |
NitroMed, Inc.
NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA. | - |
| Jane A. Kramer | F | 68 |
NitroMed, Inc.
NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA. | 3 years |
| Gerald Bruce | M | 68 |
NitroMed, Inc.
NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA. | 2 years |
| Joshua D. Hamermesh | M | 51 | 3 years | |
| Thomas Lategan | M | 65 |
NeurAxon, Inc.
NeurAxon, Inc. Miscellaneous Commercial ServicesCommercial Services NeurAxon, Inc. is engaged in the research and development of growing and unmet needs for chronic pain management. It is focused on developing pain therapeutics targeting neuronal Nitric Oxide Synthase (nNOS) inhibitors. The companyw as founded in 2004 and is headquartered in Mississauga, ON. | 7 years |
| Jeanette W. Kohlbrenner | F | - | 10 years | |
| Paul Melone | M | - | 15 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 56 | 93.33% |
| Canada | 4 | 6.67% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Lawrence Bloch
- Personal Network
